Skip to content
OpenCapital
Get started

Cytokinetics CYTK Liabilities Related To Revenue Participation Right Purchase Agreement Net

Liabilities Related To Revenue Participation Right Purchase Agreement Net at other companies

Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
$75.73M+291%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$551.35M+1.7%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$309M—
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$557.77M+4.0%
Arrowhead Research logo
Arrowhead ResearchARWR
$383.83M+9.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$1.25M—

Other financials

Income statement

See full
Revenue$19.4M+1,126%
Operating income-$183.6M-18.0%
Net income-$206.0M-27.7%
EPS (diluted)-$1.67-22.8%

Balance sheet

See full
Cash & equivalents$129.8M+76.2%
Total debt$418.2M+75.8%
Total equity-$826.6M-210%
Total assets$1.3B+0.7%

Cash flow

See full
Operating cash flow-$145.5M-10.5%
CapEx$5.9M+4.7%
Free cash flow-$151.4M-10.3%

Valuation

See full
Market cap$10.7B+70.6%
Enterprise value$10.98B+70.7%
P/S101.1×-225×

Profitability

See full
Operating margin-605.1%-268pp
Net margin-784%-337pp
FCF margin-518.8%-223pp

Returns & leverage

See full
Return on equity-337.6%—
Debt / equity2.2×—
Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept cytk:LiabilitiesRelatedToRevenueParticipationRightPurchaseAgreementNet.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's liabilities related to revenue participation right purchase agreement net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytokinetics's liabilities related to revenue participation right purchase agreement net?
Cytokinetics (CYTK) reported liabilities related to revenue participation right purchase agreement net of $539.11M in Q1 2026.
How has Cytokinetics's liabilities related to revenue participation right purchase agreement net changed year-over-year?
Cytokinetics's liabilities related to revenue participation right purchase agreement net increased by 13.2% year-over-year, from $476.3M to $539.11M.
What is the long-term trend for Cytokinetics's liabilities related to revenue participation right purchase agreement net?
Over 5 years (2020 to 2025), Cytokinetics's liabilities related to revenue participation right purchase agreement net has grown at a 25.7% compound annual growth rate (CAGR), from $166.07M to $520.56M.
What does liabilities related to revenue participation right purchase agreement net mean?
A debt-like obligation to pay a share of future revenue to an investor in exchange for cash today.
How do you interpret liabilities related to revenue participation right purchase agreement net?
An increase indicates the company has monetized future revenue streams to fund current operations, which may reduce future cash flow.
How does liabilities related to revenue participation right purchase agreement net compare across companies?
Specific to companies with high-value intellectual property or late-stage clinical assets.